(Q44577584)

4 December 2017

title

Pharmacokinetics and metabolism of chlorambucil in patients with malignant disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498170

7 July 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(79)80008-0

11 June 2023

1 reference

3

Catovsky D

1 reference

4 December 2017

A. McLean

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498170

7 July 2022

R. L. Woods

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498170

7 July 2022

P. Farmer

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498170

7 July 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=498170

7 July 2022

publication date

1 June 1979

1 reference

full work available at URL

4 December 2017

https://api.elsevier.com/content/article/PII:S0305737279800080?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(79)80008-0

https://api.elsevier.com/content/article/PII:S0305737279800080?httpAccept=text/plain

11 June 2023

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(79)80008-0

11 June 2023

published in

Cancer Treatment Reviews

1 reference

4 December 2017

volume

6 Suppl

1 reference

4 December 2017

page(s)

33-42

1 reference

Clinical evaluation of CB 1348 in leukemias and lymphomas

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2879%2980008-0

7 January 2021

CHLORAMBUCIL THERAPY FOR LYMPHOMAS AND CHRONIC LYMPHOCYTIC LEUKEMIA

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2879%2980008-0

7 January 2021

N-(2-chloroethyl)-N-(2-hydroxyethyl)arylamines. Possible intermediates to potential carcinolytic agents bearing dissimilar reactive functions

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2879%2980008-0

7 January 2021

Clinical trials of p-(di-2-chloroethylamino)-phenylbutyric acid (CB 1348) in malignant lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2879%2980008-0

7 January 2021

Proceedings: Bi-weekly chlorambucil treatment of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2879%2980008-0

7 January 2021

Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2879%2980008-0

7 January 2021

The metabolism of chlorambucil

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2879%2980008-0

7 January 2021

The clinical use of chlorambucil: a critical study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2879%2980008-0

7 January 2021

Metabolic disposition of chlorambucil in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2879%2980008-0

7 January 2021

Pharmaco-kinetics of melphalan following oral or intravenous administration in patients with malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2879%2980008-0

7 January 2021

Steroids. LXXXIII. Effects of some steroidal alkylating agents on experimental animal mammary tumor and leukemia systems

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2879%2980008-0

7 January 2021

Journal of the Chemical Society

4

2386

Everett

1953

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(79)80008-0

11 June 2023

Identifiers

1 reference

4 December 2017

1 reference